SCHEDULE: Laurence Lytton Discloses 6.8% Stake in DNA X, Inc.

Laurence W. Lytton has reported beneficial ownership of 100,521 shares, representing 6.8% of DNA X, Inc.'s common stock, as of June 30, 2026.

Summary

• Laurence W. Lytton has filed a Schedule 13G, indicating beneficial ownership of 100,521 shares of DNA X, Inc. common stock.
• This holding represents 6.8% of the company's outstanding common stock.
• The filing date for this event is June 30, 2026.
• The calculation of the percentage is based on 1,488,268 shares outstanding as of May 14, 2026, per the issuer's Form 10-Q.
• The reported shares exclude warrants to purchase 22,222 shares, subject to a 4.99% beneficial ownership limitation.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, primarily due to the disclosure of significant beneficial ownership, indicating investor confidence, but lacking specific forward-looking financial performance data.

Positives

• Laurence W. Lytton, a significant individual investor, has disclosed a substantial beneficial ownership stake of 6.8% in DNA X, Inc.
• The disclosure indicates a level of confidence or strategic interest in the company by the reporting person.
• The reporting person has sole voting and dispositive power over 61,633 shares and shared power over 38,888 shares.

Negatives

• The filing does not provide any specific financial performance data or forward-looking guidance for DNA X, Inc.
• The exclusion of warrants from the reported beneficial ownership might indicate potential future dilution or complex ownership structures.

Risks

• The 4.99% beneficial ownership limitation on warrants could restrict future share acquisition or influence for the reporting person.
• The calculation of outstanding shares is based on a prior quarter's filing (March 31, 2026), and the current number may differ.

Future Outlook

No specific forward-looking statements or guidance are provided in this Schedule 13G filing.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant individual shareholders to report their holdings. This filing indicates a substantial individual investment in DNA X, Inc., which could be interpreted as a signal of confidence by that investor.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by an individual investor may influence market perception and potentially trading activity.
• Management: The substantial holding may lead to increased engagement or scrutiny from the reporting person.
• Potential Investors: This filing provides information on a key shareholder, which can be a factor in investment decisions.

Next Steps

• Monitor future filings by Laurence W. Lytton for any changes in beneficial ownership.
• Observe DNA X, Inc.'s performance and strategic announcements for context regarding this investment.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, DNA X, Inc., Laurence W. Lytton, Common Stock, Investment, Shareholder